Published in Diabetes Technol Ther on February 01, 2004
Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care (2009) 0.98
A review of insulin pen devices and use in the elderly diabetic population. Clin Med Insights Endocrinol Diabetes (2010) 0.89
Effectiveness of groups for adolescents with type 1 diabetes mellitus and their parents. Fam Syst Health (2013) 0.82
Closed-loop glucose control: psychological and behavioral considerations. J Diabetes Sci Technol (2011) 0.82
Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis. BMC Endocr Disord (2015) 0.77
The suboptimal roadmap to the intensive therapy target. Diabetes Technol Ther (2004) 0.75
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med (2009) 6.89
Autoimmune polyendocrine syndromes. N Engl J Med (2004) 5.11
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care (2005) 5.04
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 4.30
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet (2011) 3.13
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes (2012) 3.11
Predictors of acute complications in children with type 1 diabetes. JAMA (2002) 3.04
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics (2004) 2.65
Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther (2009) 2.54
Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care. Diabetes Technol Ther (2012) 2.43
Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care (2010) 2.18
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2006) 2.15
Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA (2007) 2.04
Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest (2002) 1.98
CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun (2005) 1.96
Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther (2009) 1.88
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care (2007) 1.87
Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatr Diabetes (2002) 1.83
Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol (2009) 1.83
Glycemic control in prepubertal years. Diabetes Care (2003) 1.80
Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med (2004) 1.69
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
A United States cost-benefit comparison of an apodized, diffractive, presbyopia-correcting, multifocal intraocular lens and a conventional monofocal lens. J Cataract Refract Surg (2008) 1.64
Autoimmune polyglandular syndromes. Nat Rev Endocrinol (2010) 1.60
Altered Toll-like receptor signaling pathways in human type 1 diabetes. J Mol Med (Berl) (2010) 1.60
Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care (2010) 1.57
Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr (2010) 1.53
In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care (2003) 1.49
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care (2005) 1.43
Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther (2010) 1.39
Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Technol (2012) 1.38
Measuring adherence to antihypertensive drug therapy. J Manag Care Pharm (2004) 1.37
Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol (2011) 1.28
Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract (2010) 1.28
Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther (2013) 1.26
B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes Care (2013) 1.25
Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes (2002) 1.23
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. J Clin Invest (2014) 1.22
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes Care (2013) 1.21
Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care (2009) 1.20
Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab (2004) 1.20
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest (2015) 1.19
Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med (2011) 1.18
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care (2011) 1.17
Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care (2014) 1.17
Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes. Diabetes Technol Ther (2004) 1.17
Missed insulin boluses for snacks in youth with type 1 diabetes. Diabetes Care (2009) 1.15
The increasing onset of type 1 diabetes in children. J Pediatr (2012) 1.13
Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care (2007) 1.12
Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care (2010) 1.11
Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation. J Immunol (2011) 1.10
Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Pediatr (2007) 1.06
Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther (2007) 1.06
Surgical resident's training in colonoscopy: numbers, competency, and perceptions. Surg Endosc (2010) 1.06
Continuous glucose monitoring in youth with type 1 diabetes. Diabetes Technol Ther (2009) 1.05
Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes. Diabetes (2012) 1.05
Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. J Pediatr (2006) 1.04
Prediabetes: prediction and prevention trials. Endocrinol Metab Clin North Am (2004) 1.03
Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technol Ther (2008) 1.01
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J Pharmacol Exp Ther (2005) 1.01
Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine. Diabetes Res Clin Pract (2004) 1.00
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther (2014) 0.99
Type 1 diabetes intervention trials 2007: where are we and where are we going? Curr Opin Endocrinol Diabetes Obes (2007) 0.99
Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care (2005) 0.98
The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am (2002) 0.95
Outcome measures for outpatient hypoglycemia prevention studies. J Diabetes Sci Technol (2011) 0.95
Differences in hospital length-of-stay, charges, and mortality in congestive heart failure patients. Congest Heart Fail (2004) 0.94
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endocrinol Metab (2010) 0.92
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol (2004) 0.91
The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther (2010) 0.91
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab (2009) 0.91
Predicting asthma outcomes in commercially insured and Medicaid populations? Am J Manag Care (2013) 0.89
Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes. Pediatr Diabetes (2008) 0.89
Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes. Diabetes Technol Ther (2015) 0.88
HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J Immunol (2004) 0.87
Prevention strategies for type 1 diabetes. Rev Endocr Metab Disord (2006) 0.87
Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr (2004) 0.86
Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol (2012) 0.85
Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care (2008) 0.84
Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children. Diabetes Technol Ther (2006) 0.84
Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease. Respir Res (2012) 0.84
A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. Pediatrics (2009) 0.84
Outcomes associated with timing of maintenance treatment for COPD exacerbation. Am J Manag Care (2012) 0.84
Secondary attack rate of type 1 diabetes in Colorado families. Diabetes Care (2005) 0.83
Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population. J Med Econ (2010) 0.82
Dominant suppression of Addison's disease associated with HLA-B15. J Clin Endocrinol Metab (2011) 0.82
Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes (2014) 0.81
Utility of colonoscopy in the evaluation of diarrhea in solid organ transplant recipients. Transplantation (2009) 0.81
Endoscopic ultrasound-guided pancreatic pseudocyst cystogastrostomy using a novel self-expandable metal stent with antimigration system: A case series. Endosc Ultrasound (2015) 0.81
Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocr Pract (2003) 0.80